• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/12

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

12 Cards in this Set

  • Front
  • Back
Clinical HHT
Synonym
Osler-Weber-Rendu
Inheritance
Autosomal dominant HHT1: endoglin gene on 9q33 34 Autosomal dominant HHT2: ALK1 gene on chromosome 12
Prenatal
DNA linkage analysis or mutation detection
Incidence
1 2:100,000; M=F; all races, most common in whites
Age at Presentation
Early childhood to young adulthood with epistaxis in 50% of patients Cutaneous, gastrointestinal telangiectasias usually begins in the third to fourth decade
Pathogenesis
HHTI: Mutation in endoglin gene on chromosome 9q33 34, a transforming growth factor (TGF) p binding protein on endothelial cells essential for angiogenesis HHT2: Mutation on chromosome 12 encoding for activin receptor like kinase I (ALKI) expressed on endothelial cells
Clinical
Skin
Telangiectasias on face, palms, soles, subungual region

Mucous Membranes
Telangiectasias on vermillion, oral and nasopharyngeal mucosa, conjunctiva

Ear Nose Throat
Epistaxis recurrent in more than 80% of patients

Gastrointestinal
Telangiectasias with secondary hemorrhage; hepatic AVMs

Pulmonary
Arteriovenous fistulas complicated by hemorrhage, cerebral abscesses
D/Dx
CREST syndrome Generalized essential telangiectasia Ataxia telangiectasia (p. Il 2) Fabry disease (p. 306)
Lab
Chest x ray screen, follow up MRI if positive
Complete blood count (CBC)
Guaiac stool screen Endoscopy if symptomatic
Management
Referral to otolaryngologist cautery, packing, estrogen, septal dermoplasty for recurrent epistaxis; transfusions, iron supplementation

Referral to gastroenterologist if symptomatic Referral to thoracic surgeon excision, embolization of A V fistula

Referral to dermatologist pulsed dye laser for telangiectasias
Prognosis
HHT1 families have increased incidence of pulmonary A V fistulaes

HHT2 families with increase in hepatic AVMs